#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	768	CRP	633	633	99.53	CRP.l15.c17.ctg.1	1108	36.9	0	.	p	.	0	K29T	NONSYN	85	87	AAG	310	312	ACG	33;34;32	A;C;G	33;34;32	.	CRP is a global regulator that represses MdtEF multidrug efflux pump expression.;CRP
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	396	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l6.c4.ctg.1	248	29.8	0	.	n	.	0	T879G	SNP	879	879	T	46	46	G	8	G	8	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	396	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l6.c4.ctg.1	248	29.8	0	.	n	.	0	G880A	SNP	880	880	G	47	47	A	9	A	9	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	396	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l6.c4.ctg.1	248	29.8	0	.	n	.	0	A888G	SNP	888	888	A	55	55	G	10	G	10	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	396	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l6.c4.ctg.1	248	29.8	0	.	n	.	0	C897G	SNP	897	897	C	64	64	G	15	G	15	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	396	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l6.c4.ctg.1	248	29.8	0	.	n	.	0	T898C	SNP	898	898	T	65	65	C	15	C	15	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	396	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l6.c4.ctg.1	248	29.8	0	.	n	.	0	G906T	SNP	906	906	G	73	73	T	25	T	25	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	396	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l6.c4.ctg.1	248	29.8	0	.	n	.	0	G908A	SNP	908	908	G	75	75	A	27	A	27	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	396	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l6.c4.ctg.1	248	29.8	0	.	n	.	0	A918T	SNP	918	918	A	85	85	T	28	T	28	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	396	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l6.c4.ctg.1	248	29.8	0	.	n	.	0	A943G	SNP	943	943	A	110	110	G	66	G	66	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	396	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l6.c4.ctg.1	248	29.8	0	.	n	.	0	G991T	SNP	991	991	G	158	158	T	51	T	51	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2774	Escherichia_coli_EF_Tu	1230	1211	99.67	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1453	94.3	1	SNP	p	R234F	1	.	.	700	702	TTC	942	944	TTC	102;100;101	T;T;C	102;99;101	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R234F:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2774	Escherichia_coli_EF_Tu	1230	1211	99.67	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1453	94.3	1	SNP	p	R334C	0	.	.	1000	1002	CGT	1242	1244	CGT	137;140;139	C;G;T	137;140;139	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R334C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2774	Escherichia_coli_EF_Tu	1230	1211	99.67	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1453	94.3	0	HET	.	.	.	C144T	.	144	144	C	386	386	C	60	C,T	36,24	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2774	Escherichia_coli_EF_Tu	1230	1211	99.67	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1453	94.3	0	HET	.	.	.	T180C	.	180	180	T	422	422	T	87	T,C	41,36	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2774	Escherichia_coli_EF_Tu	1230	1211	99.67	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1453	94.3	0	HET	.	.	.	T90C	.	90	90	T	332	332	T	73	T,C	45,28	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2774	Escherichia_coli_EF_Tu	1230	1211	99.67	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1453	94.3	0	HET	.	.	.	C261T	.	261	261	C	503	503	C	122	C,T	68,52	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2774	Escherichia_coli_EF_Tu	1230	72	100.0	Escherichia_coli_EF_Tu.l15.c17.ctg.3	181	10.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	920	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c4.ctg.1	1804	27.2	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1579	1581	AAA	18;17;15	A;A;A	18;17;15	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	1260	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l6.c30.ctg.1	1863	36.0	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1290	1292	GAA	33;34;34	G;A;A	33;32;34	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	262	H_NS	414	414	99.03	H_NS.l15.c30.ctg.1	798	17.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS;H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.4	724	137.9	0	.	n	.	0	T1041G	SNP	1041	1041	T	16	16	G	167	G	134	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.4	724	137.9	0	.	n	.	0	A1042T	SNP	1042	1042	A	17	17	T	175	T	142	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.4	724	137.9	0	.	n	.	0	A1136G	SNP	1136	1136	A	111	111	G	234	G	232	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.4	724	137.9	0	.	n	.	0	T1138C	SNP	1138	1138	T	113	113	C	222	C	222	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.4	724	137.9	0	.	n	.	0	T1142C	SNP	1142	1142	T	117	117	C	202	C,A	201,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.4	724	137.9	0	.	n	.	0	C1170T	SNP	1170	1170	C	145	145	T	186	T	186	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.4	724	137.9	0	.	n	.	0	T1220C	SNP	1220	1220	T	195	195	C	190	C	189	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.4	724	137.9	0	.	n	.	0	T1245C	SNP	1245	1245	T	220	220	C	171	C,G	170,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.4	724	137.9	0	.	n	.	0	G1253A	SNP	1253	1253	G	228	228	A	178	A	178	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.4	724	137.9	0	.	n	.	0	G1256A	SNP	1256	1256	G	231	231	A	180	A	178	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.4	724	137.9	0	.	n	.	0	C1258A	SNP	1258	1258	C	233	233	A	184	A	183	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.4	724	137.9	0	.	n	.	0	G1266T	SNP	1266	1266	G	241	241	T	171	T	168	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.4	724	137.9	0	.	n	.	0	T1267C	SNP	1267	1267	T	242	242	C	170	C	170	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.4	724	137.9	0	.	n	.	0	T1275C	SNP	1275	1275	T	250	250	C	159	C	159	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.4	724	137.9	0	.	n	.	0	G1276A	SNP	1276	1276	G	251	251	A	156	A	156	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.4	724	137.9	0	.	n	.	0	A1281G	SNP	1281	1281	A	256	256	G	148	G	148	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.4	724	137.9	0	.	n	.	0	T1283C	SNP	1283	1283	T	258	258	C	146	C	146	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.4	724	137.9	0	.	n	.	0	G1288T	SNP	1288	1288	G	263	263	T	151	T	150	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.4	724	137.9	0	.	n	.	0	A1296G	SNP	1296	1296	A	271	271	G	174	G	174	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.4	724	137.9	0	.	n	.	0	T1299G	SNP	1299	1299	T	274	274	G	182	G	182	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.4	724	137.9	0	.	n	.	0	A1300T	SNP	1300	1300	A	275	275	T	183	T	182	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.4	724	137.9	0	.	n	.	0	C1356T	SNP	1356	1356	C	331	331	T	204	T	204	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.4	724	137.9	0	.	n	.	0	A1358G	SNP	1358	1358	A	333	333	G	191	G,T	190,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.4	724	137.9	0	.	n	.	0	T1368C	SNP	1368	1368	T	343	343	C	144	C	141	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.4	724	137.9	0	.	n	.	0	G1370A	SNP	1370	1370	G	345	345	A	141	A	138	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.4	724	137.9	0	.	n	.	0	C1406.	DEL	1406	1406	C	380	380	C	83	C	82	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.4	724	137.9	0	.	n	.	0	.1409C	INS	1409	1409	T	384	384	C	76	C	76	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.4	724	137.9	0	.	n	.	0	C1431A	SNP	1431	1431	C	406	406	A	9	A	9	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.4	724	137.9	0	.	n	.	0	C1432A	SNP	1432	1432	C	407	407	A	8	A	8	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.4	724	137.9	0	.	n	.	0	A1441G	SNP	1441	1441	A	416	416	G	10	G	10	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.4	724	137.9	0	.	n	.	0	T1464C	SNP	1464	1464	T	439	439	C	21	C	21	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.4	724	137.9	0	.	n	.	0	G1473T	SNP	1473	1473	G	448	448	T	77	T	77	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.4	724	137.9	0	.	n	.	0	A1475G	SNP	1475	1475	A	450	450	G	86	G	86	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.4	724	137.9	0	.	n	.	0	A1548T	SNP	1548	1548	A	523	523	T	68	T	68	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.4	724	137.9	1	SNP	n	C1194G	0	.	.	1194	1194	C	169	169	C	187	C	185	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.4	724	137.9	0	HET	.	.	.	C1040T	.	1040	1040	T	15	15	C	144	C,T	66,45	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c30.ctg.5	188	56.4	0	.	n	.	0	T50C	SNP	50	50	T	55	55	C	35	C	35	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c30.ctg.5	188	56.4	0	.	n	.	0	G74A	SNP	74	74	G	79	79	A	7	A	7	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c30.ctg.5	188	56.4	0	.	n	.	0	G81.	DEL	81	81	G	85	85	A	7	A	7	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c30.ctg.5	188	56.4	0	.	n	.	0	A83C	SNP	83	83	A	87	87	C	7	C	7	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c30.ctg.5	188	56.4	0	.	n	.	0	T92G	SNP	92	92	T	96	96	G	9	G	9	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c30.ctg.5	188	56.4	0	.	n	.	0	C94.	DEL	94	94	C	97	97	T	9	T,C	8,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c30.ctg.5	188	56.4	0	.	n	.	0	T97C	SNP	97	97	T	100	100	C	9	C	9	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c30.ctg.5	188	56.4	0	.	n	.	0	T128C	SNP	128	128	T	131	131	C	49	C	49	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c30.ctg.5	188	56.4	0	.	n	.	0	T135A	SNP	135	135	T	138	138	A	65	A	65	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c30.ctg.5	188	56.4	0	.	n	.	0	G139C	SNP	139	139	G	142	142	C	72	C	70	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c30.ctg.5	188	56.4	0	.	n	.	0	T142G	SNP	142	142	T	145	145	G	78	G	77	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c30.ctg.5	188	56.4	0	.	n	.	0	G159A	SNP	159	159	G	162	162	A	97	A,T	95,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c30.ctg.5	188	56.4	0	.	n	.	0	G161T	SNP	161	161	G	164	164	T	103	T	103	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c30.ctg.5	188	56.4	0	.	n	.	0	T168G	SNP	168	168	T	171	171	G	99	G	99	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3736	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c30.ctg.5	188	56.4	0	.	n	.	0	C170T	SNP	170	170	C	173	173	T	92	T	89	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1084	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1548	37.4	0	.	p	.	0	H2R	NONSYN	4	6	CAT	230	232	CGT	27;27;29	C;G;T	27;27;29	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1084	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1548	37.4	0	.	p	.	0	V30I	NONSYN	88	90	GTC	314	316	ATC	46;45;45	A;T;C	46;45;45	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1084	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1548	37.4	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1073	1075	GGC	43;42;42	G;G;C	43;42;42	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1312	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2020	34.5	0	.	p	.	0	R8S	NONSYN	22	24	AGA	179	181	AGC	10;10;10	A;G;C	10;10;10	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1312	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2020	34.5	0	.	p	.	0	I142L	NONSYN	424	426	ATA	581	583	CTA	32;31;31	C;T;A	32;31;31	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1312	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2020	34.5	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1100	1102	CAA	41;40;41	C,A;A;A	40,1;40;41	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1312	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2020	34.5	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1199	1201	GGT	60;58;58	G;G;T	60;58;58	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1312	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2020	34.5	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1769	1771	GTT	20;19;16	G;T;T	20;19;16	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	526	PmrE	1167	1167	96.83	PmrE.l6.c4.ctg.1	1555	18.0	0	.	p	.	0	A125E	NONSYN	373	375	GCA	562	564	GAA	13;13;13	G;A;A	13;13;13	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	526	PmrE	1167	1167	96.83	PmrE.l6.c4.ctg.1	1555	18.0	0	.	p	.	0	M185T	NONSYN	553	555	ATG	742	744	ACC	7;7;7	A;C;C	7;7;7	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	526	PmrE	1167	1167	96.83	PmrE.l6.c4.ctg.1	1555	18.0	0	.	p	.	0	S225T	NONSYN	673	675	TCC	862	864	ACT	19;20;21	A;C;T	19;20;21	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	526	PmrE	1167	1167	96.83	PmrE.l6.c4.ctg.1	1555	18.0	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1252	1254	ATC	6;7;9	A;T;C	6;7;9	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	880	PmrF	969	969	99.38	PmrF.l15.c4.ctg.1	1435	32.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF;PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	512	70	TEM_1+	858	225	99.11	TEM_1+.l6.c4.ctg.1	225	4.5	0	.	p	.	0	V82I	NONSYN	244	246	GTT	94	96	ATT	2;2;2	A;T;T	2;2;2	.	TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis;TEM-187
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	512	70	TEM_1+	858	397	99.24	TEM_1+.l6.c4.ctg.2	399	3.6	0	.	p	.	0	H162R	NONSYN	484	486	CAT	106	108	CGT	4;4;4	C;G;T	4;4;4	.	TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis;TEM-187
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	512	70	TEM_1+	858	67	100.0	TEM_1+.l6.c4.ctg.3	92	5.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis;TEM-187
aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	1	0	27	832	aad-	789	789	100.0	aad-.l15.c4.ctg.1	1244	35.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2662	acrD	3114	3114	99.07	acrD.l15.c4.ctg.1	3531	40.1	0	.	p	.	0	T85I	NONSYN	253	255	ACC	492	494	ATC	32;35;33	A;T;C	32;35;33	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2662	acrD	3114	3114	99.07	acrD.l15.c4.ctg.1	3531	40.1	0	.	p	.	0	V416I	NONSYN	1246	1248	GTC	1485	1487	ATC	38;40;40	A;T;C	38;40;40	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2662	acrD	3114	3114	99.07	acrD.l15.c4.ctg.1	3531	40.1	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2205	2207	AAG	26;25;26	A;A;G	26;25;26	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1084	acrE	1158	1158	98.79	acrE.l6.c30.ctg.1	1578	36.7	0	.	p	.	0	A22V	NONSYN	64	66	GCC	255	257	GTC	8;7;7	G;T;C	8;7;7	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1084	acrE	1158	1158	98.79	acrE.l6.c30.ctg.1	1578	36.7	0	.	p	.	0	S269C	NONSYN	805	807	AGC	996	998	TGC	69;71;73	T;G;C	69;71;73	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2458	acrF	3105	2598	98.04	acrF.l15.c17.ctg.1	2811	45.8	0	.	p	.	0	S46trunc	TRUNC	136	136	T	191	191	T	33	T	33	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2458	acrF	3105	2598	98.04	acrF.l15.c17.ctg.1	2811	45.8	0	.	p	.	0	G148D	NONSYN	442	444	GGC	497	499	GAC	56;56;60	G;A;C	55;56;59	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2458	acrF	3105	2598	98.04	acrF.l15.c17.ctg.1	2811	45.8	0	.	p	.	0	F240L	NONSYN	718	720	TTT	773	775	TTA	14;12;11	T;T;A	13;12;11	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2458	acrF	3105	2598	98.04	acrF.l15.c17.ctg.1	2811	45.8	0	.	p	.	0	D301N	NONSYN	901	903	GAT	956	958	AAT	38;39;39	A;A;T	38;39;39	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2458	acrF	3105	2598	98.04	acrF.l15.c17.ctg.1	2811	45.8	0	.	p	.	0	L563fs	FSHIFT	1687	1687	T	1743	1743	T	59	T	59	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	528	acrR_2	648	648	99.54	acrR_2.l15.c30.ctg.1	1122	25.1	1	SNP	p	R45C	0	.	.	133	135	CGC	347	349	CGC	39;38;37	C;G;C	39;38;37	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	356	acrS	663	663	98.64	acrS.l6.c4.ctg.1	1045	18.2	0	.	p	.	0	L34F	NONSYN	100	102	CTC	311	313	TTC	14;13;13	T;T;C	14;13;13	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	356	acrS	663	663	98.64	acrS.l6.c4.ctg.1	1045	18.2	0	.	p	.	0	E122G	NONSYN	364	366	GAG	575	577	GGG	28;28;27	G;G;G	28;28;27	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	594	adiY	762	762	99.61	adiY.l15.c4.ctg.1	1115	28.1	0	.	p	.	0	V136L	NONSYN	406	408	GTT	575	577	CTT	41;41;42	C;T;T	41;41;42	.	adiY;adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2768	alaS	2631	2631	98.86	alaS.l15.c4.ctg.1	3118	47.6	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2067	2069	GCA	62;62;63	G;C;A	62;62;63	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2768	alaS	2631	2631	98.86	alaS.l15.c4.ctg.1	3118	47.6	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2328	2330	ACC	50;48;48	A;C;C	48;48;47	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2768	alaS	2631	2631	98.86	alaS.l15.c4.ctg.1	3118	47.6	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2637	2639	GCC	34;35;36	G;C;C	34;35;36	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1392	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2266	32.4	0	.	p	.	0	G37A	NONSYN	109	111	GGT	204	206	GCT	6;6;6	G;C;T	6;6;6	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1392	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2266	32.4	0	.	p	.	0	D77E	NONSYN	229	231	GAT	324	326	GAG	9;9;10	G;A;G	9;9;10	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1392	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2266	32.4	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	360	362	TGC	14;14;15	T;G;C	14;14;15	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1392	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2266	32.4	0	.	p	.	0	I150V	NONSYN	448	450	ATT	543	545	GTT	21;21;24	G;T;T	21;21;24	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1392	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2266	32.4	0	.	p	.	0	R200H	NONSYN	598	600	CGC	693	695	CAC	38;37;37	C;A;C	38;37;37	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1392	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2266	32.4	0	.	p	.	0	T295M	NONSYN	883	885	ACG	978	980	ATG	50;50;50	A;T;G	50;48;50	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1392	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2266	32.4	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	1974	1976	CGC	22;21;21	C;G;C	22;21;21	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	496	bacA	822	822	98.54	bacA.l6.c17.ctg.1	1167	22.2	0	.	p	.	0	S221T	NONSYN	661	663	AGC	855	857	ACC	14;12;12	A;C;C	14;12;12	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	496	bacA	822	822	98.54	bacA.l6.c17.ctg.1	1167	22.2	0	.	p	.	0	P225S	NONSYN	673	675	CCG	867	869	TCG	18;17;16	T;C;G	17;17;16	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	542	baeR	723	723	97.79	baeR.l6.c30.ctg.1	1181	24.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.;baeR
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	978	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1618	31.4	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1331	1333	AAA	10;10;10	A;A;A	9;10;10	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	978	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1618	31.4	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1343	1345	GAG	10;11;12	G;A;G	9;10;12	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	978	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1618	31.4	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1349	1351	CAC	13;14;16	C;A;C	12;14;16	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	978	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1618	31.4	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1403	1405	GAG	19;19;17	G;A;G	19;19;17	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	1216	cpxA	1374	1374	98.91	cpxA.l15.c17.ctg.1	1923	33.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxA;CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	718	cpxR	699	699	99.43	cpxR.l15.c4.ctg.1	1121	34.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.;cpxR
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	798	cysB	975	975	99.28	cysB.l15.c4.ctg.1	1463	29.3	0	.	p	.	0	A146T	NONSYN	436	438	GCT	698	700	ACT	38;38;39	A;C;T	38;38;38	.	aminocoumarin resistant cysB;Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.
dfrA1.3002854.NC_010410.3676915_3677389.140	dfrA1.3002854.NC_010410.3676915_3677389.140	1	0	27	370	dfrA1_1	474	474	100.0	dfrA1_1.l15.c30.ctg.1	958	20.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	dfrA1;dfrA1 is an integron-encoded dihydrofolate reductase found in Escherichia coli
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	1070	emrA	1173	1173	98.29	emrA.l15.c30.ctg.1	1686	34.0	0	.	p	.	0	I219V	NONSYN	655	657	ATC	919	921	GTC	60;61;60	G;T;C	58;59;59	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	539	1516	emrB	1539	1539	99.74	emrB.l15.c30.ctg.1	1948	41.3	0	.	p	.	0	E197K	NONSYN	589	591	GAA	809	811	AAA	53;53;53	A;A;A	52;53;52	.	emrB;emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	1038	emrD	1191	1191	98.4	emrD.l6.c4.ctg.1	1618	34.4	0	.	p	.	0	G209S	NONSYN	625	627	GGC	829	831	AGC	21;21;21	A;G;C	21;21;21	.	EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.;emrD
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	528	26	emrE_1	333	161	90.68	emrE_1.l6.c30.ctg.1	161	2.7	0	.	p	.	0	I100V	NONSYN	298	300	ATT	143	145	GTC	2;2;2	G;T;C	2;2;2	.	emrE;EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	712	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1602	23.6	0	.	p	.	0	K176R	NONSYN	526	528	AAG	780	782	AGG	15;15;16	A;G;G	15;15;15	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	712	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1602	23.6	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1170	1172	GAC	12;12;12	G;A;C	12;12;12	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	514	emrR	531	531	100.0	emrR.l15.c4.ctg.1	1036	26.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrR;EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	974	emrY	1539	1539	99.81	emrY.l15.c4.ctg.1	1989	26.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY;emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	326	evgA	615	615	99.19	evgA.l15.c30.ctg.1	1005	17.5	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	392	394	CTG	25;26;25	C;T;G	24;26;25	.	EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.;evgA
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1772	evgS	3594	2595	97.65	evgS.l15.c30.ctg.1	2742	27.4	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	76	78	AAT	9;8;9	A;A;T	9;8;9	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1772	evgS	3594	2595	97.65	evgS.l15.c30.ctg.1	2742	27.4	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	97	99	TTA	3;3;3	T;T;A	3;3;3	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1772	evgS	3594	2595	97.65	evgS.l15.c30.ctg.1	2742	27.4	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	298	300	AAA	16;15;16	A;A;A	16;15;16	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1772	evgS	3594	2595	97.65	evgS.l15.c30.ctg.1	2742	27.4	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	1033	1035	CAT	19;19;20	C;A;T	19;19;20	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1772	evgS	3594	2595	97.65	evgS.l15.c30.ctg.1	2742	27.4	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	1087	1089	CAT	22;22;21	C;A;T	22;22;21	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1772	evgS	3594	2595	97.65	evgS.l15.c30.ctg.1	2742	27.4	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	1105	1107	AGA	19;20;20	A;G;A	19;20;20	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1772	evgS	3594	2595	97.65	evgS.l15.c30.ctg.1	2742	27.4	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	1120	1122	AAT	22;23;23	A;A;T	22;23;23	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1772	evgS	3594	2595	97.65	evgS.l15.c30.ctg.1	2742	27.4	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	1267	1269	TCC	9;10;11	T;C;C	9;10;11	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1772	evgS	3594	2595	97.65	evgS.l15.c30.ctg.1	2742	27.4	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	1432	1434	ATT	18;18;17	A;T;T	18;18;17	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1772	evgS	3594	2595	97.65	evgS.l15.c30.ctg.1	2742	27.4	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	1453	1455	GAT	14;16;16	G;A;T	14;16;16	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1772	evgS	3594	2595	97.65	evgS.l15.c30.ctg.1	2742	27.4	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	1567	1569	GTT	27;27;26	G;T;T	27;27;26	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1772	evgS	3594	2595	97.65	evgS.l15.c30.ctg.1	2742	27.4	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	1852	1854	CAC	38;35;34	C;A;C	37;34;34	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1772	evgS	3594	1002	97.21	evgS.l15.c30.ctg.2	1056	17.1	0	.	p	.	0	T38I	NONSYN	112	114	ACA	166	168	ATA	9;8;8	A;T;A	9;8;8	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1772	evgS	3594	1002	97.21	evgS.l15.c30.ctg.2	1056	17.1	0	.	p	.	0	L42V	NONSYN	124	126	CTA	178	180	GTA	4;5;5	G;T;A	4;5;5	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1772	evgS	3594	1002	97.21	evgS.l15.c30.ctg.2	1056	17.1	0	.	p	.	0	A93T	NONSYN	277	279	GCG	331	333	ACG	15;16;15	A;C;G	15;16;15	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1772	evgS	3594	1002	97.21	evgS.l15.c30.ctg.2	1056	17.1	0	.	p	.	0	A114E	NONSYN	340	342	GCA	394	396	GAA	18;18;20	G;A;A	18;18;20	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1772	evgS	3594	1002	97.21	evgS.l15.c30.ctg.2	1056	17.1	0	.	p	.	0	T127A	NONSYN	379	381	ACT	433	435	GCT	23;21;21	G;C;T	23;21;21	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1772	evgS	3594	1002	97.21	evgS.l15.c30.ctg.2	1056	17.1	0	.	p	.	0	N133D	NONSYN	397	399	AAT	451	453	GAT	17;17;17	G;A;T	17;17;16	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1772	evgS	3594	1002	97.21	evgS.l15.c30.ctg.2	1056	17.1	0	.	p	.	0	P162S	NONSYN	484	486	CCA	538	540	TCA	25;25;25	T;C;A	25;25;25	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1772	evgS	3594	1002	97.21	evgS.l15.c30.ctg.2	1056	17.1	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	667	669	CAG	11;10;13	C;A;G	11;10;13	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1772	evgS	3594	1002	97.21	evgS.l15.c30.ctg.2	1056	17.1	0	.	p	.	0	I251V	NONSYN	751	753	ATT	805	807	GTT	16;15;13	G;T;T	16;15;13	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1772	evgS	3594	1002	97.21	evgS.l15.c30.ctg.2	1056	17.1	0	.	p	.	0	N303D	NONSYN	907	909	AAT	961	963	GAT	12;11;11	G;A;T	12;11;11	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	702	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1234	30.3	1	SNP	p	P64R	0	.	.	190	192	CCA	391	393	CCA	56;57;57	C;C;A	55;57;57	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	702	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1234	30.3	1	SNP	p	P64L	0	.	.	190	192	CCA	391	393	CCA	56;57;57	C;C;A	55;57;57	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	702	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1234	30.3	1	SNP	p	P64A	0	.	.	190	192	CCA	391	393	CCA	56;57;57	C;C;A	55;57;57	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	702	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1234	30.3	1	SNP	p	P64S	0	.	.	190	192	CCA	391	393	CCA	56;57;57	C;C;A	55;57;57	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	702	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1234	30.3	1	SNP	p	P64H	0	.	.	190	192	CCA	391	393	CCA	56;57;57	C;C;A	55;57;57	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	320	gadE	528	528	100.0	gadE.l15.c30.ctg.1	1060	16.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.;gadE
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	16	96	gadW	729	120	97.5	gadW.l15.c17.ctg.1	120	16.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	394	gadX	825	825	97.94	gadX.l6.c30.ctg.1	938	21.2	0	.	p	.	0	F53L	NONSYN	157	159	TTC	246	248	TTA	15;15;15	T;T;A	15;15;15	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	394	gadX	825	825	97.94	gadX.l6.c30.ctg.1	938	21.2	0	.	p	.	0	V79I	NONSYN	235	237	GTT	324	326	ATT	17;15;16	A;T;T	16;15;16	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	394	gadX	825	825	97.94	gadX.l6.c30.ctg.1	938	21.2	0	.	p	.	0	R246G	NONSYN	736	738	AGA	825	827	GGA	15;15;16	G;G;A	15;15;16	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	394	gadX	825	825	97.94	gadX.l6.c30.ctg.1	938	21.2	0	.	p	.	0	S248P	NONSYN	742	744	TCG	831	833	CCG	17;18;20	C;C;G	17;18;20	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2704	gyrA_7	2628	2628	98.67	gyrA_7.l15.c4.ctg.1	3057	47.1	1	SNP	p	S83L	1	S83L	NONSYN	247	249	TCG	452	454	TTG	42;42;41	T;T;G	42;42;41	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2704	gyrA_7	2628	2628	98.67	gyrA_7.l15.c4.ctg.1	3057	47.1	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2237	2239	GAA	53;57;57	G;A;A	52;57;57	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2704	gyrA_7	2628	2628	98.67	gyrA_7.l15.c4.ctg.1	3057	47.1	1	SNP	p	D87N	0	.	.	259	261	GAC	464	466	GAC	47;47;47	G;A;C	46;47;47	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2704	gyrA_7	2628	2628	98.67	gyrA_7.l15.c4.ctg.1	3057	47.1	1	SNP	p	D87G	0	.	.	259	261	GAC	464	466	GAC	47;47;47	G;A;C	46;47;47	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2704	gyrA_7	2628	2628	98.67	gyrA_7.l15.c4.ctg.1	3057	47.1	1	SNP	p	D87V	0	.	.	259	261	GAC	464	466	GAC	47;47;47	G;A;C	46;47;47	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2704	gyrA_7	2628	2628	98.67	gyrA_7.l15.c4.ctg.1	3057	47.1	1	SNP	p	D87Y	0	.	.	259	261	GAC	464	466	GAC	47;47;47	G;A;C	46;47;47	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2704	gyrA_7	2628	2628	98.67	gyrA_7.l15.c4.ctg.1	3057	47.1	1	SNP	p	D87H	0	.	.	259	261	GAC	464	466	GAC	47;47;47	G;A;C	46;47;47	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2196	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2911	40.2	1	SNP	p	R136L	0	.	.	406	408	CGC	629	631	CGC	44;45;41	C;G;C	44;45;41	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2196	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2911	40.2	1	SNP	p	R136S	0	.	.	406	408	CGC	629	631	CGC	44;45;41	C;G;C	44;45;41	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2196	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2911	40.2	1	SNP	p	R136C	0	.	.	406	408	CGC	629	631	CGC	44;45;41	C;G;C	44;45;41	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2196	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2911	40.2	1	SNP	p	R136I	0	.	.	406	408	CGC	629	631	CGC	44;45;41	C;G;C	44;45;41	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2196	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2911	40.2	1	SNP	p	R136H	0	.	.	406	408	CGC	629	631	CGC	44;45;41	C;G;C	44;45;41	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2196	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2911	40.2	1	SNP	p	R136G	0	.	.	406	408	CGC	629	631	CGC	44;45;41	C;G;C	44;45;41	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2196	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2911	40.2	1	SNP	p	R136E	0	.	.	406	408	CGC	629	631	CGC	44;45;41	C;G;C	44;45;41	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	514	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1029	26.7	0	.	p	.	0	A72P	NONSYN	214	216	GCG	443	445	CCG	27;26;25	C;C;G	27;26;25	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	514	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1029	26.7	0	.	p	.	0	T123A	NONSYN	367	369	ACC	596	598	GCC	30;30;28	G;C;C	30;30;27	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	776	leuO	945	945	99.26	leuO.l15.c30.ctg.1	1389	29.9	0	.	p	.	0	P9S	NONSYN	25	27	CCA	202	204	TCA	29;27;28	T;C;A	29;27;28	.	leuO;leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	318	marA	384	384	99.74	marA.l15.c4.ctg.1	820	20.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	marA;In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	176	marR	435	435	97.7	marR.l15.c30.ctg.1	748	12.6	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	569	571	AGC	14;13;13	A;G;C	14;13;13	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	176	marR	435	435	97.7	marR.l15.c30.ctg.1	748	12.6	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	671	673	CAT	9;9;9	C;A;T	7;9;9	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	176	marR	435	435	97.7	marR.l15.c30.ctg.1	748	12.6	1	SNP	p	V45E	0	.	.	133	135	GTG	395	397	GTG	21;18;18	G;T;G	20;17;18	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	176	marR	435	435	97.7	marR.l15.c30.ctg.1	748	12.6	1	SNP	p	I49S	0	.	.	145	147	ATC	407	409	ATC	19;19;19	A;T;C	19;19;19	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	176	marR	435	435	97.7	marR.l15.c30.ctg.1	748	12.6	1	SNP	p	A70T	0	.	.	208	210	GCA	470	472	GCA	21;22;22	G;C;A	21;22;22	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	176	marR	435	435	97.7	marR.l15.c30.ctg.1	748	12.6	1	SNP	p	R73C	0	.	.	217	219	CGT	479	481	CGT	20;20;20	C;G;T	20;20;20	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	176	marR	435	435	97.7	marR.l15.c30.ctg.1	748	12.6	1	SNP	p	R73S	0	.	.	217	219	CGT	479	481	CGT	20;20;20	C;G;T	20;20;20	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	176	marR	435	435	97.7	marR.l15.c30.ctg.1	748	12.6	1	SNP	p	R77C	0	.	.	229	231	CGC	491	493	CGC	20;19;19	C;G;C	20;19;19	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	176	marR	435	435	97.7	marR.l15.c30.ctg.1	748	12.6	1	SNP	p	R77L	0	.	.	229	231	CGC	491	493	CGC	20;19;19	C;G;C	20;19;19	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	176	marR	435	435	97.7	marR.l15.c30.ctg.1	748	12.6	1	SNP	p	L78M	0	.	.	232	234	CTG	494	496	CTG	20;20;19	C;T;G	20;20;19	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	176	marR	435	435	97.7	marR.l15.c30.ctg.1	748	12.6	1	SNP	p	R94H	0	.	.	280	282	CGC	542	544	CGC	18;18;18	C;G;C	18;18;18	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	176	marR	435	435	97.7	marR.l15.c30.ctg.1	748	12.6	1	SNP	p	R94S	0	.	.	280	282	CGC	542	544	CGC	18;18;18	C;G;C	18;18;18	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	176	marR	435	435	97.7	marR.l15.c30.ctg.1	748	12.6	1	SNP	p	V96E	0	.	.	286	288	GTA	548	550	GTA	17;16;16	G;T;A	17;16;16	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	686	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1532	23.8	0	.	p	.	0	S7F	NONSYN	19	21	TCC	116	118	TTC	4;4;4	T;T;C	4;4;4	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	686	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1532	23.8	0	.	p	.	0	R36I	NONSYN	106	108	AGG	203	205	ATC	9;9;9	A;T;C	9;9;9	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	686	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1532	23.8	0	.	p	.	0	E42A	NONSYN	124	126	GAA	221	223	GCC	6;6;8	G;C;C	6;6;8	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	686	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1532	23.8	0	.	p	.	0	N43V	NONSYN	127	129	AAT	224	226	GTG	8;8;8	G;T;G	8;8;8	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	686	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1532	23.8	0	.	p	.	0	E52D	NONSYN	154	156	GAG	251	253	GAT	12;12;12	G;A;T	12;12;12	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	686	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1532	23.8	0	.	p	.	0	N59T	NONSYN	175	177	AAC	272	274	ACC	11;12;12	A;C;C	11;12;12	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	686	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1532	23.8	0	.	p	.	0	I68L	NONSYN	202	204	ATA	299	301	TTA	14;14;13	T;T;A	13;13;13	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	686	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1532	23.8	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	440	442	CAG	45;44;42	C,T;A;G	44,1;42;42	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	686	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1532	23.8	0	.	p	.	0	D128A	NONSYN	382	384	GAC	479	481	GCC	30;31;35	G;C,A;C	29;30,1;35	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	686	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1532	23.8	0	.	p	.	0	S163A	NONSYN	487	489	TCG	584	586	GCG	33;30;29	G;C;G	33;30;29	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	686	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1532	23.8	0	.	p	.	0	L231F	NONSYN	691	693	CTT	788	790	TTT	22;22;23	T,G;T;T	0,18;21;23	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	686	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1532	23.8	0	.	p	.	0	R285fs	FSHIFT	853	853	C	950	950	C	24	C	24	.	Multidrug translocase MdfA;mdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	684	mdtA	1248	1248	97.36	mdtA.l6.c4.ctg.1	1669	22.0	0	.	p	.	0	V12trunc	TRUNC	34	34	G	268	268	G	29	G	29	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	684	mdtA	1248	1248	97.36	mdtA.l6.c4.ctg.1	1669	22.0	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	325	327	CAG	11;12;13	C;A;G	11;12;13	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	684	mdtA	1248	1248	97.36	mdtA.l6.c4.ctg.1	1669	22.0	0	.	p	.	0	T83I	NONSYN	247	249	ACC	475	477	ATC	20;18;18	A;T;C	20;17;18	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	684	mdtA	1248	1248	97.36	mdtA.l6.c4.ctg.1	1669	22.0	0	.	p	.	0	I99M	NONSYN	295	297	ATA	523	525	ATG	24;26;26	A;T;G	24;26;26	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	684	mdtA	1248	1248	97.36	mdtA.l6.c4.ctg.1	1669	22.0	0	.	p	.	0	A130T	NONSYN	388	390	GCC	616	618	ACC	16;16;16	A;C;C	16;15;16	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	684	mdtA	1248	1248	97.36	mdtA.l6.c4.ctg.1	1669	22.0	0	.	p	.	0	P257T	NONSYN	769	771	CCG	997	999	ACG	21;20;19	A;C;G	21;20;19	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2870	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3490	43.8	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1950	1952	ACC	63;64;63	A;C;C	63;64;61	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2870	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3490	43.8	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2343	2345	CAA	32;33;32	C;A;A	31;32;31	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2870	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3490	43.8	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2511	2513	ATT	29;29;30	A;T;T	29;29;30	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2870	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3490	43.8	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2595	2597	GTT	57;58;60	G;T;T	57;58;60	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2870	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3490	43.8	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2703	2705	GAG	25;25;26	G;A;G	25;25;26	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2870	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3490	43.8	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2931	2933	ATG	24;24;23	A;T;G	24;24;23	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2870	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3490	43.8	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3066	3068	GAT	36;36;36	G;A;T	36;35;35	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2618	mdtC	3078	3078	98.64	mdtC.l6.c4.ctg.1	3536	39.5	0	.	p	.	0	I46M	NONSYN	136	138	ATC	334	336	ATG	22;21;20	A;T;G	21;21;19	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2618	mdtC	3078	3078	98.64	mdtC.l6.c4.ctg.1	3536	39.5	0	.	p	.	0	V208I	NONSYN	622	624	GTC	820	822	ATC	54;53;53	A;T;C	54;53;53	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2618	mdtC	3078	3078	98.64	mdtC.l6.c4.ctg.1	3536	39.5	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3136	3138	CAC	5;5;5	C;A;C	5;5;5	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2618	mdtC	3078	3078	98.64	mdtC.l6.c4.ctg.1	3536	39.5	0	.	p	.	0	P981L	NONSYN	2941	2943	CCC	3139	3141	CTC	5;6;6	C;T;C	5;6;6	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1124	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1832	32.8	0	.	p	.	0	D3E	NONSYN	7	9	GAT	205	207	GAA	27;27;25	G;A;A	27;26;25	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1124	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1832	32.8	0	.	p	.	0	T226A	NONSYN	676	678	ACG	874	876	GCG	37;37;37	G;C;G	37;36;36	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1124	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1832	32.8	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1216	1218	ATC	37;36;37	A;T;C	35;35;34	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1124	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1832	32.8	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1519	1521	TTT	37;36;34	T;T;T	37;36;34	.	Efflux pump mdtD;mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	1296	mdtE	1158	1158	99.31	mdtE.l15.c4.ctg.1	1585	43.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtE;MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	2740	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3588	40.7	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1124	1126	ACC	20;21;21	A;C;C	20;21;21	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	2740	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3588	40.7	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2366	2368	GAC	58;56;57	G;A;C	57;56;57	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	982	mdtG	1227	1047	99.33	mdtG.l15.c4.ctg.1	1446	30.1	0	.	p	.	0	V200I	NONSYN	598	600	GTC	610	612	ATC	36;36;37	A;T;C	36;36;37	.	Efflux protien mdtG.;mdtG
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	982	mdtG	1227	182	99.45	mdtG.l15.c4.ctg.2	702	11.9	0	.	p	.	0	E5G	NONSYN	13	15	GAA	270	272	GGA	6;7;7	G;G;A	6;7;7	.	Efflux protien mdtG.;mdtG
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	978	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1598	32.8	0	.	p	.	0	G134C	NONSYN	400	402	GGT	610	612	TGT	49;52;52	T;G;T	48;51;52	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	978	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1598	32.8	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1180	1182	TTG	31;32;32	T;T;G,T	31;32;30,1	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	978	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1598	32.8	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1390	1392	ACG	14;14;14	A;C;G	14;14;14	.	mdtH;Multidrug resistance protein MdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	946	mdtL	1176	1176	98.38	mdtL.l15.c30.ctg.1	1642	30.8	0	.	p	.	0	A185S	NONSYN	553	555	GCC	773	775	TCC	22;22;23	T;C;C	22;22;23	.	mdtL;Multidrug resistance protein MdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	748	mdtN	1032	1032	98.06	mdtN.l15.c30.ctg.1	1542	25.9	0	.	p	.	0	V119I	NONSYN	355	357	GTT	629	631	ATT	22;21;22	A;T;T	22;21;22	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.;mdtN
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1760	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2383	39.4	0	.	p	.	0	V11M	NONSYN	31	33	GTG	186	188	ATG	24;26;27	A;T;G	23;25;27	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1760	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2383	39.4	0	.	p	.	0	T33I	NONSYN	97	99	ACC	252	254	ATC	26;26;26	A;T;C	26;26;26	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1760	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2383	39.4	0	.	p	.	0	C116R	NONSYN	346	348	TGC	501	503	CGC	53;54;52	C;G;C	52;54;52	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1760	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2383	39.4	0	.	p	.	0	N238S	NONSYN	712	714	AAC	867	869	AGC	39;39;38	A;G;C	39;37;37	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1760	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2383	39.4	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1068	1070	GTG	40;39;38	G;T;G	40;35;37	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1760	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2383	39.4	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1131	1133	AAC	17;15;16	A;A;C	16;13;15	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1760	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2383	39.4	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1176	1178	GTC	28;29;29	G;T;C	27;28;29	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1760	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2383	39.4	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1206	1208	ATA	47;47;49	A;T;A	47;47;49	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1760	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2383	39.4	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1314	1316	TCT	32;33;33	T;C;T	32;33;33	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1760	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2383	39.4	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1701	1703	GCG	48;46;47	G;C;G	47;46;46	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1760	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2383	39.4	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1914	1916	ATC	41;42;42	A;T;C	41;42;42	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1074	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1902	30.2	0	.	p	.	0	S129A	NONSYN	385	387	TCA	606	608	GCG	38;40;40	G;C;G	38;39;39	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1074	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1902	30.2	0	.	p	.	0	A187T	NONSYN	559	561	GCC	780	782	ACC	46;45;46	A;C;C	46;45;46	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1074	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1902	30.2	0	.	p	.	0	H211R	NONSYN	631	633	CAC	852	854	CGC	37;37;42	C;G;C	37;36;42	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1074	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1902	30.2	0	.	p	.	0	V250A	NONSYN	748	750	GTT	969	971	GCT	34;35;35	G;C;T	32;35;35	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1074	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1902	30.2	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1053	1055	AAA	14;13;13	A;A;A	14;13;13	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1074	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1902	30.2	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1071	1073	CGA	17;15;15	C;G;A	17;15;15	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1074	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1902	30.2	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1236	1238	GCC	26;26;26	G;C;C	26;26;26	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1074	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1902	30.2	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1248	1250	GAT	28;26;25	G;A;T	28;26;25	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1074	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1902	30.2	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1665	1667	GCT	18;17;18	G;C;T	18;17;18	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	2974	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3879	40.7	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1538	1540	AAG	27;28;28	A;A;G	27;28;28	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	2974	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3879	40.7	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2615	2617	CTG	44;45;43	C;T;G	43;44;42	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	154	mgrB	144	144	100.0	mgrB.l15.c17.ctg.2	167	25.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB;mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1688	msbA	1749	1749	98.68	msbA.l15.c17.ctg.1	2137	42.3	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1019	1021	AAC	31;31;30	A;A;C	31;30;30	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1688	msbA	1749	1749	98.68	msbA.l15.c17.ctg.1	2137	42.3	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1565	1567	ATA	51;51;51	A;T;A	51;50;51	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1318	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1681	41.7	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1313	1315	GAT	67;67;64	G;A;T	66;66;63	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1318	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1681	41.7	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1316	1318	CTG	64;64;63	C;T;G	64;64;63	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	528	284	nfsA	723	405	99.01	nfsA.l15.c30.ctg.1	888	16.9	0	.	p	.	0	R27C	NONSYN	79	81	CGT	293	295	TGT	24;24;24	T;G;T	24;24;24	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	528	284	nfsA	723	405	99.01	nfsA.l15.c30.ctg.1	888	16.9	0	.	p	.	0	I117T	NONSYN	349	351	ATC	563	565	ACC	25;25;25	A;C;C	25;25;25	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	528	284	nfsA	723	405	99.01	nfsA.l15.c30.ctg.1	888	16.9	1	SNP	p	R15C	0	.	.	43	45	CGC	257	259	CGC	32;33;33	C;G;C,A	32;33;32,1	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	528	284	nfsA	723	405	99.01	nfsA.l15.c30.ctg.1	888	16.9	1	SNP	p	S33R	0	.	.	97	99	AGC	311	313	AGC	23;22;22	A;G;C	23;21;22	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	528	284	nfsA	723	405	99.01	nfsA.l15.c30.ctg.1	888	16.9	1	SNP	p	G131D	0	.	.	391	393	GGC	605	607	GGC	16;16;16	G;G;C	16;16;16	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1112	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1575	37.6	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1173	1175	GAG	36;35;32	G;A;G	36;35;32	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1112	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1575	37.6	1	SNP	p	G141E	0	.	.	421	423	GGT	660	662	GGT	55;57;56	G;G;T	55;57;56	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1112	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1575	37.6	1	SNP	p	G141D	0	.	.	421	423	GGT	660	662	GGT	55;57;56	G;G;T	55;57;56	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1112	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1575	37.6	1	SNP	p	R154A	0	.	.	460	462	CGT	699	701	CGT	68;69;71	C;G;T	68;69;71	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1112	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1575	37.6	1	SNP	p	R154D	0	.	.	460	462	CGT	699	701	CGT	68;69;71	C;G;T	68;69;71	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2460	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2685	49.0	0	.	p	.	0	A533V	NONSYN	1597	1599	GCG	1834	1836	GTG	65;64;63	G;T;G	64;63;63	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2460	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2685	49.0	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1861	1863	TCG	48;50;51	T;C;G	39;45;48	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2460	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2685	49.0	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2476	2478	AAC	34;34;33	A;A;C	34;34;33	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2460	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2685	49.0	1	SNP	p	A85T	0	.	.	253	255	GCG	490	492	GCG	61;60;62	G;C;G	59;57;60	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2460	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2685	49.0	1	SNP	p	D111H	0	.	.	331	333	GAT	568	570	GAT	42;41;43	G;A;T	42;41;43	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2460	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2685	49.0	1	SNP	p	S129P	0	.	.	385	387	TCC	622	624	TCC	61;61;61	T;C;C	61;61;61	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1398	parE_1	1893	1893	97.52	parE_1.l15.c30.ctg.1	2379	31.4	0	.	p	.	0	D473N	NONSYN	1417	1419	GAC	1662	1664	AAC	48;49;48	A;A;C	48;49;48	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1398	parE_1	1893	1893	97.52	parE_1.l15.c30.ctg.1	2379	31.4	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1671	1673	GAT	47;48;47	G;A;T	47;48;47	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1304	patA	1380	1380	99.78	patA.l15.c30.ctg.1	1858	37.4	0	.	p	.	0	P202Q	NONSYN	604	606	CCG	839	841	CAG	37;35;36	C;A;G	37;35;36	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1304	patA	1380	1380	99.78	patA.l15.c30.ctg.1	1858	37.4	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1313	1315	GAT	61;58;57	G;A;T	61;57;57	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4304	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4551	50.6	1	SNP	p	V146F	0	.	.	436	438	GTT	670	672	GTT	45;42;42	G;T;T	45;42;41	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4304	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4551	50.6	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1771	1773	CAG	58;58;60	C;A;G	58;58;60	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4304	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4551	50.6	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1771	1773	CAG	58;58;60	C;A;G	58;58;60	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4304	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4551	50.6	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1810	1812	CAC	35;32;34	C;A;C	35;32;34	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4304	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4551	50.6	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1819	1821	CGT	35;36;36	C;G;T	35;36;36	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4304	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4551	50.6	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1819	1821	CGT	35;36;36	C;G;T	35;36;36	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4304	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4551	50.6	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1825	1827	TCC	37;38;36	T;C;C	37;38;35	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4304	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4551	50.6	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1831	1833	CTC	38;39;38	C;T;C	38;39;38	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4304	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4551	50.6	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1921	1923	ACC	58;58;59	A;C;C	58;58;59	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4304	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4551	50.6	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1924	1926	CCT	59;59;57	C,A;C;T	58,1;59;57	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4304	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4551	50.6	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2293	2295	CGT	103;104;102	C;G;T	103;103;101	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	10878	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1708	319.9	0	.	n	.	0	A226G	SNP	226	226	A	380	380	G	367	G	366	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	10878	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1708	319.9	1	SNP	n	A794T	0	.	.	794	794	A	948	948	A	325	A	320	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	10878	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1708	319.9	1	SNP	n	A794G	0	.	.	794	794	A	948	948	A	325	A	320	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	10878	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1708	319.9	1	SNP	n	G926C	0	.	.	926	926	G	1080	1080	G	327	G	327	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	10878	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1708	319.9	1	SNP	n	G926T	0	.	.	926	926	G	1080	1080	G	327	G	327	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	10878	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1708	319.9	1	SNP	n	G926A	0	.	.	926	926	G	1080	1080	G	327	G	327	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	10878	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1708	319.9	1	SNP	n	A1519C	0	.	.	1519	1519	A	1673	1673	A	194	A	189	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	10878	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1708	319.9	1	SNP	n	A1519T	0	.	.	1519	1519	A	1673	1673	A	194	A	189	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	10878	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1708	319.9	1	SNP	n	A1519G	0	.	.	1519	1519	A	1673	1673	A	194	A	189	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	10878	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1708	319.9	0	HET	.	.	.	G1002A	.	1002	1002	G	1156	1156	G	305	G,A	190,114	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	10878	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1708	319.9	0	HET	.	.	.	G1006C	.	1006	1006	G	1160	1160	G	301	G,C	181,115	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	10878	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1708	319.9	0	HET	.	.	.	A79G	.	79	79	A	233	233	A	297	A,G	228,65	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	10878	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1708	319.9	0	HET	.	.	.	C719T	.	719	719	C	873	873	C	281	C,T	164,116	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	10878	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1708	319.9	0	HET	.	.	.	T273A	.	273	273	T	427	427	T	336	T,A	249,82	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	10878	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1708	319.9	0	HET	.	.	.	T1010C	.	1010	1010	T	1164	1164	T	304	T,C	190,109	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	10878	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1708	319.9	0	HET	.	.	.	C1038T	.	1038	1038	C	1192	1192	C	314	C,T	192,122	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	10878	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1708	319.9	0	HET	.	.	.	C183T	.	183	183	C	337	337	C	277	C,T	192,84	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	10878	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1708	319.9	0	HET	.	.	.	T90C	.	90	90	T	244	244	T	295	T,C	231,64	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	10878	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1708	319.9	0	HET	.	.	.	A250T	.	250	250	A	404	404	A	349	A,T	257,91	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	10878	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1708	319.9	0	HET	.	.	.	G474A	.	474	474	G	628	628	G	338	G,A	254,81	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	10878	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1708	319.9	0	HET	.	.	.	A253T,C	.	253	253	A	407	407	A	351	A,T,C	259,90,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	10878	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1708	319.9	0	HET	.	.	.	C194T	.	194	194	C	348	348	C	305	C,T	248,54	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
sat_1.3002895.AB211124.0_525.584	sat_1.3002895.AB211124.0_525.584	1	0	27	572	sat_1	525	525	100.0	sat_1.l15.c17.ctg.1	851	34.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	sat-1 is a plasmid-mediated streptothricin acetyltransferase in Escherichia coli;sat-1
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	464	soxR	465	465	100.0	soxR.l6.c17.ctg.1	894	27.7	1	SNP	p	R20H	0	.	.	58	60	CGC	266	268	CGC	43;45;45	C;G;C	43;45;44	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	464	soxR	465	465	100.0	soxR.l6.c17.ctg.1	894	27.7	1	SNP	p	G121D	0	.	.	361	363	GGT	569	571	GGT	42;42;44	G;G;T	42;42;43	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	296	soxS_1	324	324	99.69	soxS_1.l15.c4.ctg.1	778	20.5	1	SNP	p	A12S	0	.	.	34	36	GCA	248	250	GCA	41;40;40	G;C;A	41;40;40	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
strA.manually_added_NC_009345_WP_001082319.1_6656_7459	strA.manually_added_NC_009345_WP_001082319.1_6656_7459	1	0	27	432	APH_3____Ib+	804	804	100.0	APH_3____Ib+.l15.c30.ctg.1	1205	19.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
strB.manually_added_NC_009345_WP_000480968.1_7459_8295	strB.manually_added_NC_009345_WP_000480968.1_7459_8295	1	0	27	450	APH_6__Id+	837	837	100.0	APH_6__Id+.l15.c4.ctg.1	1237	19.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
sul2.manually_added_NC_009345_WP_001043267.1_5780_6595	sul2.manually_added_NC_009345_WP_001043267.1_5780_6595	1	0	539	330	sul2	816	816	99.88	sul2.l15.c30.ctg.1	1118	15.5	0	.	p	.	0	A240P	NONSYN	718	720	GCA	831	833	CCA	4;5;5	C,G;C;A	0,3;4;3	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	1	0	27	452	tetA	1200	1200	100.0	tetA.l6.c30.ctg.1	1634	14.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetR.manually_added_NC_009345_WP_000164043.1_474_1124	tetR.manually_added_NC_009345_WP_000164043.1_474_1124	1	0	539	300	tetR	651	651	97.7	tetR.l15.c4.ctg.1	1046	15.1	0	.	p	.	0	D152_S153del	DEL	454	454	G	685	685	G	24	G	24	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	1478	tolC	1488	1488	98.72	tolC.l15.c4.ctg.1	1896	41.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.;tolC
